I recommend that the article (today 10-6-2011) in Pharmalot, "Drug Maker Floods FDA With Patient Death Reports", be read. If you recall, Actelion and Amgen had been discussing a future together. This article is a good fit with the earlier report in Pharmalot, recommending NO buyout. Close call!
Also, the Washington Post article about Kevin was quite thorough.
Also, the Washington Post article about Kevin was quite thorough.